Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:3/27/2019
Start Date:December 20, 2017
End Date:December 26, 2019
Contact:Toll Free Number
Email:Trialsites@merck.com
Phone:1-888-577-8839

Use our guide to learn which trials are right for you!

A Phase 4 Randomized, Active-Comparator Controlled Clinical Trial to Study the Safety of Sugammadex (MK-8616) for the Reversal of Neuromuscular Blockade Induced by Either Rocuronium Bromide or Vecuronium Bromide in American Society of Anesthesiologists (ASA) Class 3 or 4 Subjects

This is a randomized, active comparator-controlled, parallel-group, multi-site, double-blind
safety trial of sugammadex (MK-8616) for the reversal of neuromuscular blockade (NMB) induced
by rocuronium or vecuronium in adult ASA Physical Status Class 3 and 4 participants. The
first primary objective of this study is to characterize the incidence of treatment emergent
sinus bradycardia, treatment emergent sinus tachycardia, or other treatment emergent cardiac
arrhythmias after administration of sugammadex. The second primary objective of this study is
to evaluate the general safety of sugammadex in a population of ASA Class 3 and 4 subjects in
a surgical setting.


Inclusion Criteria:

- Has a body mass index (BMI) < 40 kg/m2.

- Is categorized as ASA Physical Status Class 3 or 4, as determined by the Investigator.

- Has a planned surgical procedure that requires NMB with either rocuronium or
vecuronium.

- Has a planned surgical procedure (e.g., gastrointestinal, urologic, or laparoscopic)
that in the opinion of the investigator does not preclude maintenance of moderate or
deep depth of NMB throughout the case.

- If female who is not of reproductive potential, is one of the following: (1)
postmenopausal; (2) has had a hysterectomy and/or bilateral oophorectomy, bilateral
salpingectomy, or bilateral tubal ligation/occlusion at least 6 weeks prior to
screening; (3) has a congenital or acquired condition that prevents childbearing; or
(4) is undergoing surgical sterilization (e.g., hysterectomy or tubal ligation) as the
planned surgical procedure associated with participation in this study.

- If female who is sexually active and of child-bearing potential, agrees to use a
medically accepted method of contraception through seven days after receiving
protocol-specified medication. Abstinence (relative to heterosexual activity) can be
used as the sole method of contraception if it is consistently employed as the
subject's preferred and usual lifestyle and if considered acceptable by local
regulatory agencies and Ethics Review Committees/Institutional Review Boards.

- Is able to provide (or the participant's legally authorized representative, in
accordance with local requirements), written informed consent for the trial. The
participant or legally authorized representative may also provide consent for Future
Biomedical Research.

Exclusion Criteria:

- Has a pacemaker or automatic implantable cardioverter-defibrillator that precludes the
assessment of bradycardia or arrhythmias.

- Has a medical condition or surgical procedure that precludes reversal of neuromuscular
block at the end of surgery.

- Has a neuromuscular disorder(s) that may affect neuromuscular block and/or trial
assessments.

- Is dialysis-dependent or has severe renal insufficiency (defined as estimated
creatinine clearance of <30 mL/min.

- Has or is suspected of having a personal history or family history (parents,
grandparents, or siblings) of malignant hyperthermia.

- Has or is suspected of having an allergy (e.g., hypersensitivity and/or anaphylactic
reaction) to study treatments or its/their excipients, to opioids/opiates, muscle
relaxants or their excipients, or other medication(s) used during general anesthesia.

- Has received or is planned to receive toremifene within 24 hours before or within 24
hours after study medication administration.

- Has any condition that would contraindicate the administration of study medication.

- Is pregnant, is attempting to become pregnant, or is lactating.

- Is currently participating in or has participated in an interventional clinical trial
(including any other current or ongoing trial with a sugammadex treatment arm) with an
investigational compound or device within 30 days of signing the informed consent form
of this current trial.
We found this trial at
20
sites
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
Phone: 913-945-7420
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
Phone: 205-996-7383
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
75 Francis street
Boston, Massachusetts 02115
(617) 732-5500
Phone: 617-732-2192
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
?
mi
from
Boston, MA
Click here to add this to my saved trials
1500 Northwest 12th Avenue # 106
Miami, Florida 33136
Phone: 305-585-3746
?
mi
from
Miami, FL
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Phone: 615-322-2564
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
Asheville, North Carolina 28801
Phone: 828-213-5987
?
mi
from
Asheville, NC
Click here to add this to my saved trials
Cleveland, Ohio 44195
Phone: 216-445-8281
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Columbia, Missouri 65203
Phone: 919-636-0354
?
mi
from
Columbia, MO
Click here to add this to my saved trials
4 Lustenauer Straße
Dornbirn, Voralberg 6850
Phone: +4355723032100
?
mi
from
Dornbirn,
Click here to add this to my saved trials
2001 Hermann Drive
Houston, Texas 77004
Phone: 713-480-3028
?
mi
from
Houston, TX
Click here to add this to my saved trials
11234 Anderson St
Loma Linda, California 92354
(909) 558-4000
Phone: 909-558-8493
Loma Linda University Medical Center An outgrowth of the original Sanitarium on the hill in...
?
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Milwaukee, Wisconsin 53295
Phone: 414384200042429
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Neptune, New Jersey 07754
Phone: 732-776-3398
?
mi
from
Neptune, NJ
Click here to add this to my saved trials
New Brunswick, New Jersey 08901
Phone: 732-745-8600
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
New Orleans, Louisiana 70121
Phone: 504-842-5530
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
New Orleans, Louisiana 70112
Phone: 504-988-5068
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
3401 N Broad St
Philadelphia, Pennsylvania
(215) 707-2000
Phone: 215-707-3325
Temple University Hospital On January 18, 1892 a three-story house at 3403 North Broad Street...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Royal Oak, Michigan 48314
Phone: 248-898-0833
?
mi
from
Royal Oak, MI
Click here to add this to my saved trials
2315 Stockton Blvd.
Sacramento, California 95817
(916) 734-2011
Phone: 916-734-5048
University of California, Davis Medical Center UC Davis Medical Center serves a 65,000-square-mile area that...
?
mi
from
Sacramento, CA
Click here to add this to my saved trials
Tucson, Arizona 85724
Phone: 520-626-7636
?
mi
from
Tucson, AZ
Click here to add this to my saved trials